STUDY SEARCH RESULTS

1 study found for your search request:  5475-013

MK-5475-013 INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of MK-5475 (an Inhaled sGC Stimulat...
Condition: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease
Minimum Age: 40 years, Maximum Age: 85 years
Gender: All
Study ID: NCT05612035
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site